Tilray Earnings Review |
November 14, 2018 | November 2018 Bond Updates |
Tilray Inc. fell over 5% after hours after the Canadian pharmaceutical and cannabis company reported earnings. Tilray lost 20 cents last quarter which missed the Street's estimate for a 14 cent loss. |
View more at: https://www.forbes.com/sites/adamsarhan/2018/11/13/tilray-earnings-review/ |
Related News |
|